curacle co.,ltd. (KOSDAQ:365270)
South Korea · Delayed Price · Currency is KRW 16,650
+220 (1.34%)
At close: Mar 6, 2026
curacle co.,ltd. Market Cap
curacle co.,ltd. has a market cap or net worth of 354.71 billion as of March 6, 2026. Its market cap has increased by 280.46% in one year.
Market Cap
354.71B
Enterprise Value
339.70B
Revenue
1.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
16,650.00
Market Cap Chart
Since July 22, 2021, curacle co.,ltd.'s market cap has decreased from 409.36B to 354.71B, a decrease of -13.35%. That is a compound annual growth rate of -3.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 354.71B | 136.80% |
| Dec 30, 2025 | 149.80B | 79.35% |
| Dec 30, 2024 | 83.52B | -48.17% |
| Dec 28, 2023 | 161.14B | 2.54% |
| Dec 29, 2022 | 157.15B | -49.31% |
| Dec 30, 2021 | 310.02B | -24.27% |
| Jul 22, 2021 | 409.36B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IntoCell | 656.77B |
| HansBiomed | 633.27B |
| S.Biomedics | 443.39B |
| Y-Biologics | 346.82B |
| NIBEC | 334.16B |
| ABION | 254.54B |
| Bio Solution | 244.14B |
| Genome & Company | 223.32B |